Article

Polymorphism in IFNAR contributes to glucocorticoid response and outcome in ARDS and…

medRxiv: the preprint server for health sciences · 2022 · Juho Jalkanen, author Sofia Khan, author Kati Elima, author Teppo Huttunen, author Ning Wang, author Maija Hollmén, author Laura L. Elo, author Sirpa Jalkanen, author

Key facts

Title Polymorphism in IFNAR contributes to glucocorticoid response and outcome in ARDS and COVID-19
First author Juho Jalkanen, author Sofia Khan, author Kati Elima, author Teppo Huttunen, author Ning Wang, author Maija Hollmén, author Laura L. Elo, author Sirpa Jalkanen, author
Journal medRxiv : the preprint server for health sciences
Published Jul 7, 2022
DOI 10.1101/2022.03.10.22272123
Devices mentioned K042152, K940422, K982100
Product codes mentioned CFN, DFZ, PFF, PFT

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature